Clinical Trial Update: Changing the coUrse of cRohn's Disease With an Early Use of Adalimumab [Phase 4]

View source ↗

Summary

Clinical trial update reporting phase 4 study on early use of adalimumab for Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | Conditions: CD | Phase 4 | Status: UNKNOWN